Data as of Nov 26
| +0.04 / +0.38%|
The 3 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 12.00, with a high estimate of 20.00 and a low estimate of 11.00. The median estimate represents a +12.57% increase from the last price of 10.66.
The current consensus among 3 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.